Nordic Insights Archives

News Nordic Insights

A pharmaceutical company’s strategy in public procurement and tendering

Participation in hospital procurement and tendering is not just an operational requirement, but a key aspect of pharmaceutical companies’ market access strategy. By engaging in…

Tero Sandberg24/04/2026

News Nordic Insights

The Role of Real-World Evidence in Nordic Health Technology Assessment

Real-world evidence (RWE) has become increasingly visible in health technology assessment (HTA) discussions across Europe. In the Nordic countries, however, its role remains distinctive —…

Saku Torvinen27/03/2026

News Nordic Insights

Unlocking the Nordics: Pharma Strategies That Deliver Impact

Unlocking the Nordics: The Nordic countries may seem like small markets in terms of population, but their importance in pharmaceutical commercialization should not be underestimated.…

Tero Ylisaukko-oja01/10/2025

News Nordic Insights

Key Trends Shaping the Future of Medical Affairs

Over the past decade, medical affairs has undergone a deeper transformation than perhaps any other function in the pharmaceutical industry. What was once viewed as…

Tero Ylisaukko-oja26/08/2025

News Nordic Insights

Turning Real-World Evidence into Real Impact

Generating high-quality real-world evidence (RWE) takes serious effort. Compared to many other activities, it’s quite resource-heavy, time-consuming, and expensive. But too often, teams pour everything…

Tero Ylisaukko-oja03/06/2025

News Nordic Insights

Winning Over Healthcare Professionals in a Noisy Digital World

Let’s be honest: when it comes to digital communication, pharma has historically lagged behind. Winning Over Healthcare Professionals in a Noisy Digital World: While other…

Tero Ylisaukko-oja28/04/2025

News Nordic Insights

Rare Disease Era: Why Pharma’s Playbook Needs a Rewrite

Medicines for rare diseases are no longer a niche category—they’re dominating drug approvals and reshaping the industry. In 2024, over one-third of all EMA positive…

Tero Ylisaukko-oja02/04/2025

News Nordic Insights

The Nordic Opportunity: Turning Real-World Data into a Rare Disease Research Powerhouse

Over the past decade, rare diseases have gone from a niche to a major focus in pharma, thanks to regulatory incentives and advances in precision…

Tero Ylisaukko-oja21/02/2025

Nordic Insights

Recent Posts